Loss of Heterozygosity on chromosome Xp22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas

Journal of Korean Medical Science

Volumn 13, Issue 3, 1998, Pages 311-316

  Choi, Chan ^a   Kim, Mi Hwa ^a   Juhng, Sang Woo ^a  

^a Chonnam National University   (South Korea)

Author keywords

Breast neoplasms; Genes, suppressor, tumor; Loss of heterozygosity; X chromosome

Indexed keywords

DNA;

ADENOCARCINOMA; ADULT; ALLELE; ARTICLE; BREAST TUMOR; FEMALE; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MIDDLE AGED; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

ADENOCARCINOMA; ADULT; ALLELES; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; POLYMORPHISM, GENETIC; X CHROMOSOME;

EID: 0032087818     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1998.13.3.311     Document Type: Article

References (37)

1. Ponder B. Gene losses in human tumors. Nature 1988; 335: 400-3.
2. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White R. Expression of recessive alleles by chromosomal mechanism in retinoblastoma. Nature 1983; 305: 779-84.
3. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Loss of heterozygosity of chromosome 3p markers in small cell lung cancer. Nature 1989; 329: 451-4.
4. Ali IV, Lidereau R, Theillet C, Callahan R. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science 1988; 238: 185-8.
5. Vogelstein B, Fearon ER, Hamilton SR, Kern DE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
6. Seizinger BR, Klinger HP, Julien C, Nakamura Y, Le Beau M, Cavenee W, Emanuel B, Ponder B, Naylor S, Mitelman F, Louis D, Menon A, Newsham I, Decker J, Kaelbling M, Henry I, von Deimling A. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 1991; 58: 1080-96.
7. Loupart M-L, Adams S, Armour JAL, Walker R, Brammar W, Varley J. Loss of heterozygosity on the X chromosome in human breast cancer. Genes Chromosome Cancer 1995; 13: 229-38.
8. Larsson C, Bystrom C, Skoog L, Rotstein S, Nordenskjold M. Genomic alterations in human breast carcinomas. Genes Chromosome Cancer 1990; 2: 191-7.
9. Devilee P, van Vleit M, van Sloun P, Kuipers-Dijkshoorn N, Hermans J, Pearson PL, Cornelisse CJ. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991; 6: 1705-11.
10. Dracopoli NC, Alhadeff B, Houghton AN, Old LJ. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res 1987; 47: 3995-4000.
11. Yang-Feng TL, Li S, Han H, Schwartz PE. Frequent loss of heterozygosity on chromosome Xp and 13q in human ovarian cancer. Int J Cancer 1992; 52: 575-80.
12. Yang-Feng TL, Han H, Chen K-C, Li S, Claus EB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE. Allelic loss in ovarian cancer. Int J Cancer 1993; 54: 546-51.
13. Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Juhng SW, Lee JB, Chenevix-Trench G, Kim S, Barrett, Koi M. Loss of heterozygosity at chromosome Xq25-26.1 in advanced human ovarian carcinomas. Genes Chromosome Cancer 1997; 20: 234-42.
14. Blood HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-65.
15. Ignar-Trowbridge D, Risinger JI, Dent GA, Kohler M, Berchuck A, McLachlan JA, Boyd J. Mutation of Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 1992; 167: 227-32.
16. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M. A second-generation linkage map of the human genome. Nature 1992; 359: 794-801.
17. Bouloux PMG, Hardelin JP, Munroe P, Kirk JNW, Legouis R, Levilliers J, Hazan J, Weissenbach J, Petit C. A dinucleotide repeat polymorphism at the Kallman locus (Xp22.3). Nucleic Acids Res 191; 19: 5453.
18. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J. The 1993-94 genethon human genetic linkage map. Nature Genet 1994; 7: 246-339.
19. Clemens PR, Fenwick RG, Chamberlain JS, Gibbs RA, de Andrade M, Chakraborty R. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphism. Am J Hum Genet 1991; 49: 951-60.
20. Hinds HL, Hendriks RW, Craig IW, Chen ZX. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 1992; 13: 896-7.
21. Edwards A, Hammond HA, Jin L, Caskey T, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992; 12: 241-53.
22. Nelson DL, Ballabio A, Cremers F, Monaco AP, Schlessinger D. Report of the sixth international workshop on X chromosome mapping 1995. Cytogenet Cell Genet 1995; 71: 308-36.
23. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlated with X chromosome inactivation. Am J Hum Genet 1992; 51: 1229-39.
24. Bassam BJ, Anolles GC, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 1991; 196: 80-3.
25. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3.
26. Osborne RJ, Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 1994; 69: 429-38.
27. Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, Podratz KC, Jenkins RB. Human epithelial ovarian cancer allelotype. Cancer Res 1993; 53: 2393-8.
28. Iwabuchi H, Sakamoto M, Sakamura H, Ma Y-Y, Carcangi ML, Pinkel D, Yang-Feng TL, Gray JW. Genetic analysis of benign, low-grade and high grade ovarian tumors. Cancer Res 1995; 55: 6172-80.
29. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994; 54: 4481-7.
30. Trash-Bingham CA, Salazar H, Greenberg RE, Tartof KD. Loss of heterozygosity studies indicate that chromosome arm 1p harbours a tumor suppressor gene for renal oncocytomas. Genes Chomosome Cancer 1996; 16: 64-7.
31. Noguchi T, Mallei MG, Oberle I, Planche J, Imbert J, Pelassy C, Birg F, Birnbaum D. Localization of the mcf 2 transforming sequence to the X chromosome. EMBO J 1987; 6: 1301-7.
32. Sawyer JR, Tryka AF, Bell JM, Boop FA. Nonrandom chromosome breakpoints at Xq26 and 2q33 characterize cemento-ossifying fibromas of the orbit. Cancer 1995; 76: 1853-9.
33. Sandberg AA. The X chromosome in human neoplasia, including sex chromatin and congenital conditions with X-chromosom anormalies. In: Sandberg AA, ed. Cytogenetics of the mammalian X chromosome, part B: X chromosome anomalies and their clinical manifestations. New York: Alan R Liss, 1983: 459-98.
34. Moertel CA, Dahl RJ, Stalboerger PG, Kimmel DW, Scheithauer BW, Jenkins RB. Gliosis specimens contain clonal cytogenetic abnormalities. Cancer Genet Cytogenet 1993; 67: 21-7.
35. Wang N, Cedrone E, Skuse GR, Insel R, Dry J. Two identical X chromosome in human mammary carcinoma cells. Cancer Genet Cytogenet 1990; 46: 271-80.
36. Klein CB, Conway K, Wang XW, Bhamra RK, Lin X, Cohen MD, Annab L, Barrett JC, Costa M. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science 1993; 251: 796-9.
37. Wang XW, Lin X, Klein CB, Bhamra RK, Lee Y-W, Costa MA. A conserved region in human and Chinese hamster X chromosomes can induce cellular senescence on nickel-transformed Chinese hamster cell lines. Carcinogenesis 1992; 13: 555-61.